Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Cash from Operations (2016 - 2025)

MedWellAI (MWAI) has disclosed Cash from Operations for 11 consecutive years, with 84968.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 60.79% to 84968.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 642704.0, a 71.98% increase, with the full-year FY2025 number at 848531.0, up 79.45% from a year prior.
  • Cash from Operations was 84968.0 for Q4 2025 at MedWellAI, up from 170781.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 707026.0 in Q1 2022 to a low of 1362542.0 in Q4 2023.
  • A 5-year average of 487562.85 and a median of 308190.5 in 2021 define the central range for Cash from Operations.
  • Biggest YoY gain for Cash from Operations was 324.06% in 2022; the steepest drop was 261965.98% in 2022.
  • MedWellAI's Cash from Operations stood at 32824.0 in 2021, then tumbled by 816.5% to 300831.0 in 2022, then plummeted by 352.93% to 1362542.0 in 2023, then skyrocketed by 84.1% to 216691.0 in 2024, then skyrocketed by 60.79% to 84968.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Cash from Operations are 84968.0 (Q4 2025), 170781.0 (Q3 2025), and 108803.0 (Q2 2025).